$55.35
+1.46 (+2.70%)
At Close: Jul 31, 2026
Cognizant will use Claude models and agentic tooling in Cognizant platforms to help clients modernize and scale AI adoption. Cognizant will provide Claude to up to 350,000 associates across key corpor
Here is Why Growth Investors Should Buy Cognizant (CTSH) Now
11:59pm, Monday, 03'rd Nov 2025
Cognizant (CTSH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Anthropic Lands Cognizant as Enterprise AI Customer
05:48pm, Monday, 03'rd Nov 2025
Anthropic signed up the professional-services firm in one of its biggest deals yet as the artificial intelligence startup looks to make its Claude models the preferred AI for businesses.
Cognizant Q3 Earnings Beat Estimates: Will Raised View Aid Shares?
04:01pm, Thursday, 30'th Oct 2025
CTSH posts a solid Q3 earnings and revenue beat, lifts full-year outlook on strong North America and AI-driven growth.
Cognizant Technology Solutions Corporation (CTSH) Q3 2025 Earnings Call Transcript
04:06pm, Wednesday, 29'th Oct 2025
Cognizant Technology Solutions Corporation ( CTSH ) Q3 2025 Earnings Call October 29, 2025 8:30 AM EDT Company Participants Tyler Scott - Vice President of Investor Relations Ravi Kumar S - CEO & Dire
Cognizant Technology Solutions' Shares Jump on Strong Q3 Earnings
01:52pm, Wednesday, 29'th Oct 2025
Cognizant Technology Solutions beat on both earnings and revenue Wednesday morning, extending a streak of consistent outperformance while signaling that its AI strategy is beginning to pay off.
Cognizant: Value Play With A Potential Upside With 3Q25
01:27pm, Wednesday, 29'th Oct 2025
Cognizant (CTSH) is rated a "BUY" with a conservative target, citing undervaluation. CTSH stands out among IT/AI consulting peers for its solid fundamentals, strong M&A activity, and impressive foreca
Cognizant CEO: AI being used to displace human capital is a mistake
11:57am, Wednesday, 29'th Oct 2025
Ravi Kumar S. Cognizant CEO, joins 'Money Movers' to discuss the company's quarterly earnings results, what AI is doing to the labor pool and much more.
Cognizant (CTSH) Surpasses Q3 Earnings and Revenue Estimates
08:41am, Wednesday, 29'th Oct 2025
Cognizant (CTSH) came out with quarterly earnings of $1.39 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.25 per share a year ago.
Cognizant raises annual adjusted profit forecast on strong client spending
08:06am, Wednesday, 29'th Oct 2025
Cognizant Technology raised its full-year 2025 adjusted profit forecast on Wednesday, anticipating a surge in spending from enterprise clients looking to upgrade their digital infrastructure with arti
Cognizant Reports Third Quarter 2025 Results
06:30am, Wednesday, 29'th Oct 2025
Revenue of $5.42 billion increased 7.4% year-over-year or 6.5% in constant currency1, above the high end of our guidance range, and 3.2% sequentially or 2.8% in constant currency, driven by North Amer
Cognizant's AI Lab Announces Breakthrough Research for Fine-Tuning LLMs and Records its 61st U.S. Patent Issuance
11:33am, Tuesday, 28'th Oct 2025
TEANECK, N.J. , Oct. 28, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) today announced a breakthrough from its AI Lab that introduces a novel, efficiency-focused method for fine-tuning large langua
Why Cognizant (CTSH) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 28'th Oct 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cognizant to Report Q3 Earnings: What's in Store for the Stock?
03:15pm, Monday, 27'th Oct 2025
CTSH's third-quarter 2025 performance is likely to have benefited from an expanding clientele and a robust pipeline that includes a favorable mix of new opportunities.
Cognizant and Rubrik Announce Strategic Partnership to Deliver Business Resilience-as-a-Service
08:00am, Monday, 27'th Oct 2025
Partnership advances outcome-based cyber resilience, combining AI-driven security and global scale to move from reactive recovery to proactive resilience. TEANECK, N.J.
Sign In
Buy CTSH